Deoxyribonucleic acid degradation and the lethal effect by myxin in Escherichia coli.
Exposure of Escherichia coli 15T(-) cells to the antibiotic myxin results in the inhibition of deoxyribonucleic acid (DNA) biosynthesis, degradation of intracellular DNA, and death of the cells. Each of these effects was markedly enhanced when protein synthesis was simultaneously inhibited by chloramphenicol. In the continued presence of chloramphenicol, a brief (1 min) exposure to myxin resulted in a rate of DNA degradation and cell death equivalent to that found in the continued presence of myxin alone. Single-strand breaks were present in the DNA of cells exposed to myxin, but when chloramphenicol was also present the breaks were found much earlier. Degradation of DNA in cells exposed to myxin was found to be distributed randomly in both strands and extended over the genome with no restriction to the vicinity of the replication point. There was no release of DNA from its attachment to the cellular membrane in myxin-exposed cells. The possibility that the chloramphenicol effect is due to the inhibition of repair enzyme synthesis which is stimulated by exposure of the cells to myxin is discussed. These data indicate that the extent of the lethal and metabolic damage to the cells by an exposure to myxin represents the result of competition between damage to and repair of cellular DNA.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000096:biosynthesis; D001431:Bacteriological Techniques; D002247:Carbon Isotopes; D002462:Cell Membrane / Q000378:metabolism; D002470:Cell Survival; D002499:Centrifugation, Density Gradient; D002701:Chloramphenicol / Q000494:pharmacology; D003470:Culture Media; D004260:DNA Repair; D004269:DNA, Bacterial / Q000096:biosynthesis / Q000378:metabolism*; D004357:Drug Synergism; D004926:Escherichia coli / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D009268:Nalidixic Acid / Q000494:pharmacology; D009691:Nucleic Acid Denaturation; D010087:Oxides / Q000494:pharmacology; D010619:Phenazines / Q000494:pharmacology*; D013395:Sucrose; D013941:Thymine / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D002247:Carbon Isotopes; D003470:Culture Media; D004269:DNA, Bacterial; D010087:Oxides; D010619:Phenazines; D014316:Tritium; D009268:Nalidixic Acid; D013395:Sucrose; D002701:Chloramphenicol; D013941:Thymine; D014529:Uridine